M-A | Em pacientes com insuficiência renal dialítica, os antagonistas dos receptores de mineralocorticoide reduzem a mortalidade por causa cardiovascular e por todas as causas sem aumentar o risco de hiperpotassemia.

Efficacy and Safety of Mineralocorticoid Receptor Antagonists in Kidney Failure Patients Treated with Dialysis: A Systematic Review and Meta-Analysis – Clinical Journal of the American Society of Nephrology (link para o resumo – $ para o texto completo)

Comentário no Twitter

Patients with kidney failure have a high risk of cardiovascular diseases. This meta-analysis suggests that mineralocorticoid receptor antagonists might improve clinical outcomes of patients with kidney failure without a major increase in hyperkalemia risk https://t.co/o3aO3KK2S6 pic.twitter.com/5xuCgs6FbQ

— CJASN (@CJASN) June 14, 2021